Stay updated on Paclitaxel-Pembrolizumab vs. Weekly Paclitaxel Clinical Trial
Sign up to get notified when there's something new on the Paclitaxel-Pembrolizumab vs. Weekly Paclitaxel Clinical Trial page.

Latest updates to the Paclitaxel-Pembrolizumab vs. Weekly Paclitaxel Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedFooter updates include a new Revision: v3.3.3 notice, and the HHS Vulnerability Disclosure and Revision: v3.3.2 entries have been removed. These changes do not affect core study information, eligibility criteria, or enrollment data.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page revision marker was updated to v3.3.2 in the footer, and the previous revision entry v3.2.0 was removed.SummaryDifference0.1%

- Check44 days agoChange DetectedRemoval of the government funding status notice on the study page; study details and eligibility information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check58 days agoChange DetectedThe two screenshots depict the same study details (NCT03841747) with no changes to core content such as design, arms, eligibility, or outcomes; any differences are limited to formatting or layout.SummaryDifference0.4%

- Check87 days agoChange DetectedSummary of changes: added a government funding notice with current operating status guidance and updated version to v3.2.0; removed the old version label v3.1.0.SummaryDifference5%

- Check94 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0; no other content changes observed.SummaryDifference0.1%

Stay in the know with updates to Paclitaxel-Pembrolizumab vs. Weekly Paclitaxel Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Paclitaxel-Pembrolizumab vs. Weekly Paclitaxel Clinical Trial page.